- Source: inbox/queue/2026-02-18-medrxiv-oregon-psilocybin-services-mental-health-outcomes.md - Domain: health - Claims: 0, Entities: 2 - Enrichments: 3 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
37 lines
No EOL
1.6 KiB
Markdown
37 lines
No EOL
1.6 KiB
Markdown
# Bendable Therapy
|
|
|
|
**Type:** Psilocybin service center
|
|
**Location:** Portland, Oregon
|
|
**Status:** Operating under Oregon Measure 109
|
|
**Domain:** Psychedelic-assisted therapy
|
|
|
|
## Overview
|
|
|
|
Bendable Therapy is a psilocybin service center operating under Oregon's Measure 109 state-regulated psilocybin program. The center is notable for exceeding Oregon's minimum regulatory requirements by providing enhanced screening, multiple preparation sessions, and structured integration support.
|
|
|
|
## Research
|
|
|
|
Bendable Therapy conducted the first published outcomes study from Oregon's Measure 109 program, a prospective naturalistic study from March 2024 to April 2025. The study enrolled 91 clients with 88 completing all components, demonstrating large effect sizes for depression (d=0.90), anxiety (d=1.04), and wellbeing (d=2.14) at 30-day follow-up.
|
|
|
|
## Service Model
|
|
|
|
- Average dose: 27.8 mg Total Psilocybin Equivalents
|
|
- Session format: 56.8% individual, 43.2% group
|
|
- Integration: 80% client attendance rate
|
|
- Enhanced protocol beyond Oregon minimum requirements
|
|
|
|
## Client Demographics
|
|
|
|
The center's client base reflects significant demographic disparities:
|
|
- 87.5% white (vs. Oregon general population)
|
|
- 84.1% completed higher education
|
|
- 77.3% earning above $50K annually
|
|
- 46.6% traveling from out of state
|
|
- 64.8% with prior psilocybin experience
|
|
- Median age 43 years
|
|
|
|
## Timeline
|
|
|
|
- **2024-03** — Began prospective naturalistic outcomes study
|
|
- **2025-04** — Completed data collection for first Oregon Measure 109 outcomes study
|
|
- **2026-02-18** — Published medRxiv preprint showing large effect sizes but significant demographic disparities in access |